Strs Ohio cut its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 13.6% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 15,324 shares of the medical instruments supplier’s stock after selling 2,422 shares during the period. Strs Ohio’s holdings in DENTSPLY SIRONA were worth $993,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in DENTSPLY SIRONA by 2.7% in the first quarter. Vanguard Group Inc. now owns 22,165,069 shares of the medical instruments supplier’s stock valued at $1,383,988,000 after buying an additional 584,536 shares during the period. BlackRock Inc. boosted its position in DENTSPLY SIRONA by 3,103.7% in the first quarter. BlackRock Inc. now owns 13,891,329 shares of the medical instruments supplier’s stock valued at $867,376,000 after buying an additional 13,457,730 shares during the period. State Street Corp boosted its position in DENTSPLY SIRONA by 0.4% in the first quarter. State Street Corp now owns 9,931,689 shares of the medical instruments supplier’s stock valued at $620,136,000 after buying an additional 36,012 shares during the period. Veritas Asset Management LLP boosted its position in DENTSPLY SIRONA by 5.0% in the first quarter. Veritas Asset Management LLP now owns 6,043,539 shares of the medical instruments supplier’s stock valued at $377,359,000 after buying an additional 287,800 shares during the period. Finally, Principal Financial Group Inc. boosted its position in DENTSPLY SIRONA by 1,445.2% in the first quarter. Principal Financial Group Inc. now owns 5,292,885 shares of the medical instruments supplier’s stock valued at $330,488,000 after buying an additional 4,950,337 shares during the period. Institutional investors own 95.13% of the company’s stock.

DENTSPLY SIRONA Inc. (XRAY) opened at 53.76 on Wednesday. DENTSPLY SIRONA Inc. has a one year low of $53.21 and a one year high of $65.68. The firm’s market cap is $12.34 billion. The company’s 50-day moving average is $62.34 and its 200 day moving average is $62.34.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.65. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The business had revenue of $992.70 million during the quarter, compared to the consensus estimate of $1 billion. During the same quarter last year, the firm posted $0.76 EPS. DENTSPLY SIRONA’s revenue was down 2.9% compared to the same quarter last year. Equities analysts anticipate that DENTSPLY SIRONA Inc. will post $2.72 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 13th. Investors of record on Friday, September 29th will be given a $0.0875 dividend. This represents a $0.35 annualized dividend and a yield of 0.65%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s payout ratio is currently -10.09%.

TRADEMARK VIOLATION WARNING: This story was first reported by Watch List News and is owned by of Watch List News. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US & international trademark & copyright laws. The legal version of this story can be viewed at https://www.watchlistnews.com/dentsply-sirona-inc-xray-shares-sold-by-strs-ohio/1492959.html.

XRAY has been the subject of several research analyst reports. UBS AG reiterated a “neutral” rating and issued a $59.00 price target (down previously from $62.00) on shares of DENTSPLY SIRONA in a report on Thursday, August 10th. BidaskClub cut shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Friday, July 28th. Stifel Nicolaus restated a “buy” rating and set a $66.00 target price (down previously from $70.00) on shares of DENTSPLY SIRONA in a report on Thursday, August 10th. Zacks Investment Research cut shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Monday. Finally, Cleveland Research upgraded shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a report on Tuesday, May 23rd. Three research analysts have rated the stock with a sell rating, three have given a hold rating and eight have given a buy rating to the company’s stock. DENTSPLY SIRONA has a consensus rating of “Hold” and an average price target of $66.25.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.